FlavoLife develops senolytic drugs and medical foods to selectively clear stress-induced senescent cells, targeting premature ageing conditions. 
FlavoLife is a single company with two pathways for healthy aging and to fight senescence:
1)	Senolytic drug candidates developed as 'pan-senolytics,' designed to target a broad and diverse range of senescent cells accumulating throughout the body due to premature ageing
2)	Senolytic medical foods, to support reducing chemotherapy toxicity
Key partners
CDP Venture Capital & Cariplo Factory
Key Awards
*VitaFoods 2024: Most Innovative product – Winner
*StartCup Puglia 2022 – Winner
*Premio Nazionale dell’Innovazione 2022 - Finalist

Flavolife

Org chart

Teams

Offices